CITIUS ONCOLOGY INC(CTOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTOR CITIUS ONCOLOGY INC

休市中 12-12 16:00:00 EST

1.13

+0.00

0.00%

盘后1.13

+0.000.00%

19:18 EST

最高1.18	最低1.10	成交量16.47万
今开1.12	昨收1.13	日振幅7.05%
总市值9,437万	流通市值1,392万	总股本8,351万
成交额18.68万	换手率1.34%	流通股本1,232万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTOR","market":"US","secType":"STK","nameCN":"CITIUS ONCOLOGY INC","latestPrice":1.13,"timestamp":1765573200000,"preClose":1.13,"halted":0,"volume":164705,"hourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.13,"latestTime":"19:18 EST","volume":3297,"amount":3748.13,"timestamp":1765585103995},"delay":0,"floatShares":12321000,"shares":83513400,"eps":-0.373844,"marketStatus":"休市中","change":0,"latestTime":"12-12 16:00:00 EST","open":1.12,"high":1.1797,"low":1.1,"amount":186774.9264735,"amplitude":0.070531,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.373844,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.13,"preHourTrading":{"tag":"盘前","latestPrice":1.13,"preClose":1.13,"latestTime":"08:00 EST","volume":100,"amount":112.99999999999999,"timestamp":1765544400970},"postHourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.13,"latestTime":"19:18 EST","volume":3297,"amount":3748.13,"timestamp":1765585103995},"volumeRatio":0.3958293779730361},"requestUrl":"/m/hq/s/CTOR","defaultTab":"news","newsList":[{"id":"1194721703","title":"Citius Oncology完成1800万美元的同时注册直接发行和私募配售，价格符合纳斯达克规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1194721703","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194721703?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:31","pubTimestamp":1765402278,"startTime":"0","endTime":"0","summary":"Citius Oncology完成1800万美元的同时注册直接发行和私募配售，价格符合纳斯达克规则","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"1186772713","title":"Citius Oncology Inc - 直接发行以每股1.09美元购买1,284,404股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1186772713","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186772713?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:33","pubTimestamp":1765287209,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc - 直接发行以每股1.09美元购买1,284,404股普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","CTXR","BK4007","BK4139"],"gpt_icon":0},{"id":"1111513577","title":"Citius Oncology 宣布以市场定价进行1800万美元的注册直销及私人投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1111513577","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111513577?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:31","pubTimestamp":1765287103,"startTime":"0","endTime":"0","summary":"Citius Oncology 宣布以市场定价进行1800万美元的注册直销及私人投资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTXR","CTOR","BK4139"],"gpt_icon":0},{"id":"1178681935","title":"Citius Oncology通过与Er-Kim的独家协议扩展Lymphir™在土耳其和中东国家的分销","url":"https://stock-news.laohu8.com/highlight/detail?id=1178681935","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178681935?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:37","pubTimestamp":1764855430,"startTime":"0","endTime":"0","summary":"Citius Oncology通过与Er-Kim的独家协议扩展Lymphir™在土耳其和中东国家的分销","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTOR","CTXR","BK4139"],"gpt_icon":0},{"id":"1108685707","title":"Citius Oncology 宣布 Lymphir™ 上市，作为切肤性 T 细胞淋巴瘤的新型癌症免疫疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1108685707","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108685707?lang=zh_cn&edition=full","pubTime":"2025-12-02 01:01","pubTimestamp":1764608490,"startTime":"0","endTime":"0","summary":"Citius Oncology 宣布在美国商业化推出 Lymphir™，这是一种针对切肤性 T 细胞淋巴瘤的新型癌症免疫疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CTOR","CTXR"],"gpt_icon":0},{"id":"2585127830","title":"Citius Oncology, Inc.盘中异动 急速上涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585127830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585127830?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:30","pubTimestamp":1763735424,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日22时30分，Citius Oncology, Inc.股票出现波动，股价急速上涨5.62%。Citius Oncology, Inc.股票所在的制药行业中，整体涨幅为0.00%。其相关个股中，Shuttle Pharmaceuticals Holdings, Inc.、Scilex Holding Company C/Wts 10/11/2027 、Citius Oncology, Inc.涨幅较大，Shuttle Pharmaceuticals Holdings, Inc.、Inmed Pharmaceuticals Inc.、Citius Oncology, Inc.较为活跃，换手率分别为170.12%、3.94%、1.49%，振幅较大的相关个股有Citius Oncology, Inc.、Scynexis, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为4.42%、2.49%、2.36%。Citius Oncology, Inc.公司简介：Citius Oncology Inc 是一家专业制药公司，致力于开发和商业化针对未满足需求的重症监护产品，专注于肿瘤产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212230259777da73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511212230259777da73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"1149323781","title":"Citius Oncology与麦克森签署美国分销协议以支持Lymphir™商业推广","url":"https://stock-news.laohu8.com/highlight/detail?id=1149323781","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149323781?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:37","pubTimestamp":1760963831,"startTime":"0","endTime":"0","summary":"Citius Oncology与麦克森签署美国分销协议以支持Lymphir™商业推广","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU0868494708.USD","CTOR","BK4585","LU0122379950.USD","LU0203345920.USD","LU0861579265.USD","BK4588","CTXR","LU0251131958.USD","BK4139","LU0432979614.USD","LU0965509010.AUD","LU1366192091.USD","LU0742534661.SGD","LU1057294990.SGD","LU1585245621.USD","LU1934455863.HKD","LU1983260115.SGD","LU0314106906.USD","LU0965508806.USD","LU0048573561.USD","LU1506573853.SGD","BK4175","LU0965509101.SGD","LU0965509283.SGD","LU1023059063.AUD","LU1061106388.HKD","BK4007","LU0942090050.USD","BK4533","LU1037948541.HKD","LU1934455194.USD","LU1934455277.USD","LU2089984988.USD","MCK","LU1430594728.SGD","LU1814569148.SGD","LU2324357040.USD","LU0251142724.SGD","LU1037948897.HKD","LU2468319806.SGD","LU0203347892.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"1125386068","title":"Citius Oncology与Eversana签订独家商业化协议，助力计划于2025年第四季度推出Lymphir™","url":"https://stock-news.laohu8.com/highlight/detail?id=1125386068","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125386068?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:48","pubTimestamp":1760618892,"startTime":"0","endTime":"0","summary":"Citius Oncology与Eversana签订独家商业化协议，助力计划于2025年第四季度推出Lymphir™","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","CTXR","BK4007","BK4139"],"gpt_icon":0},{"id":"1198374736","title":"Citius Oncology宣布完成900万美元注册直接发行和同步私募配售定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1198374736","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198374736?lang=zh_cn&edition=full","pubTime":"2025-09-09 20:31","pubTimestamp":1757421080,"startTime":"0","endTime":"0","summary":"Citius Oncology宣布完成总额900万美元的注册直接发行和同步私募配售的定价工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTXR","BK4007","CTOR"],"gpt_icon":0},{"id":"2558503787","title":"Citius Oncology, Inc.8月8日成交额为28.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558503787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558503787?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:52","pubTimestamp":1754704341,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Citius Oncology, Inc.成交额为28.59万美元，成交额较昨日减少35.76%，当日成交量为15.86万股。Citius Oncology, Inc.于2025年8月8日跌2.16%，报1.81美元，该股过去5个交易日跌12.14%，年初至今涨57.39%，过去60日涨97.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|28.59万|-35.76%|15.86万|#|2025-08-07|44.50万|-15.98%|23.88万|#|2025-08-06|52.97万|-25.76%|27.11万|#|2025-08-05|71.35万|71.25%|37.14万|#|2025-08-04|41.66万|-68.78%|19.95万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095222a47e2686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095222a47e2686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2557751553","title":"Citius Oncology, Inc.8月7日成交额为44.50万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557751553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557751553?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:51","pubTimestamp":1754617861,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Citius Oncology, Inc.成交额为44.50万美元，成交额较昨日减少15.98%，当日成交量为23.88万股。Citius Oncology, Inc.于2025年8月7日跌3.14%，报1.85美元，该股过去5个交易日跌16.29%，年初至今涨60.87%，过去60日涨107.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|44.50万|-15.98%|23.88万|#|2025-08-06|52.97万|-25.76%|27.11万|#|2025-08-05|71.35万|71.25%|37.14万|#|2025-08-04|41.66万|-68.78%|19.95万|#|2025-08-01|133.44万|53.92%|61.47万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808095106a6d9dd3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808095106a6d9dd3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2557582705","title":"Citius Oncology, Inc.8月6日成交额为52.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557582705","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557582705?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:49","pubTimestamp":1754531361,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Citius Oncology, Inc.成交额为52.97万美元，成交额较昨日减少25.76%，当日成交量为27.11万股。Citius Oncology, Inc.于2025年8月6日涨5.52%，报1.91美元，该股过去5个交易日跌11.57%，年初至今涨66.09%，过去60日涨124.18%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|52.97万|-25.76%|27.11万|#|2025-08-05|71.35万|71.25%|37.14万|#|2025-08-04|41.66万|-68.78%|19.95万|#|2025-08-01|133.44万|53.92%|61.47万|#|2025-07-31|86.70万|-71.54%|38.61万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094928a479c519&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094928a479c519&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2557234640","title":"Citius Oncology, Inc.8月5日成交额为71.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557234640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557234640?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:47","pubTimestamp":1754444840,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Citius Oncology, Inc.成交额为71.35万美元，成交额较昨日增加71.25%，当日成交量为37.14万股。Citius Oncology, Inc.于2025年8月5日跌12.14%，报1.81美元，该股过去5个交易日跌12.14%，年初至今涨57.39%，过去60日涨114.2%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|71.35万|71.25%|37.14万|#|2025-08-04|41.66万|-68.78%|19.95万|#|2025-08-01|133.44万|53.92%|61.47万|#|2025-07-31|86.70万|-71.54%|38.61万|#|2025-07-30|304.60万|-10.09%|135.24万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806094724a6d57b82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806094724a6d57b82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2557355291","title":"Citius Oncology, Inc.8月4日成交额为41.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557355291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557355291?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:46","pubTimestamp":1754358393,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Citius Oncology, Inc.成交额为41.66万美元，成交额较昨日减少68.78%，当日成交量为19.95万股。Citius Oncology, Inc.于2025年8月4日涨0.0%，报2.06美元，该股过去5个交易日涨10.16%，年初至今涨79.13%，过去60日涨143.21%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|41.66万|-68.78%|19.95万|#|2025-08-01|133.44万|53.92%|61.47万|#|2025-07-31|86.70万|-71.54%|38.61万|#|2025-07-30|304.60万|-10.09%|135.24万|#|2025-07-29|338.77万|215.54%|162.66万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805094639a47575da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805094639a47575da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2556884342","title":"Citius Oncology, Inc.盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556884342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556884342?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:10","pubTimestamp":1754075424,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时10分，Citius Oncology, Inc.股票出现波动，股价大幅跳水5.43%。Citius Oncology, Inc.股票所在的制药行业中，整体涨幅为1.68%。其相关个股中，Evoke Pharma, Inc.、Alvotech C/Wts 、苏轩堂涨幅较大，Akanda Corp.、Incannex Healthcare Inc.、Evoke Pharma, Inc.较为活跃，换手率分别为357.98%、186.79%、8.67%，振幅较大的相关个股有Akanda Corp.、Evoke Pharma, Inc.、Incannex Healthcare Inc.，振幅分别为60.53%、20.09%、19.76%。Citius Oncology, Inc.公司简介：Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080203102494c98eeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080203102494c98eeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2555834383","title":"Citius Oncology, Inc.盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555834383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555834383?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:43","pubTimestamp":1753969412,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时43分，Citius Oncology, Inc.股票出现波动，股价大幅拉升5.55%。Citius Oncology, Inc.股票所在的制药行业中，整体跌幅为0.19%。其相关个股中，Medicus Pharma Ltd C/Wts 15/11/2029、Indivior Plc、博美集团涨幅较大，Incannex Healthcare Inc.、Indivior Plc、Painreform Ltd.较为活跃，换手率分别为139.71%、11.74%、7.85%，振幅较大的相关个股有Incannex Healthcare Inc.、Scilex Holding Company C/Wts 10/11/2027 、Flora Growth Corp.，振幅分别为11.22%、10.21%、9.00%。Citius Oncology, Inc.公司简介：Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731214332972a5310&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731214332972a5310&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2555096736","title":"Citius Oncology, Inc.7月29日成交额为338.77万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555096736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555096736?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:50","pubTimestamp":1753840211,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Citius Oncology, Inc.成交额为338.77万美元，成交额较昨日增加215.54%，当日成交量为162.66万股。Citius Oncology, Inc.于2025年7月29日涨10.16%，报2.06美元，该股过去5个交易日涨24.85%，年初至今涨79.13%，过去60日涨131.46%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|338.77万|215.54%|162.66万|#|2025-07-28|107.36万|-78.52%|57.44万|#|2025-07-25|499.93万|131.20%|229.49万|#|2025-07-24|216.23万|-95.36%|114.40万|#|2025-07-23|4664.69万|6627.26%|1957.31万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095018a46a8c3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095018a46a8c3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2555871086","title":"Citius Oncology, Inc.7月28日成交额为107.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555871086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555871086?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:48","pubTimestamp":1753753717,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Citius Oncology, Inc.成交额为107.36万美元，成交额较昨日减少78.52%，当日成交量为57.44万股。Citius Oncology, Inc.于2025年7月28日跌5.08%，报1.87美元，该股过去5个交易日涨26.35%，年初至今涨62.61%，过去60日涨115.44%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-28|107.36万|-78.52%|57.44万|#|2025-07-25|499.93万|131.20%|229.49万|#|2025-07-24|216.23万|-95.36%|114.40万|#|2025-07-23|4664.69万|6627.26%|1957.31万|#|2025-07-22|69.34万|31.14%|43.63万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729094845a6c6d140&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729094845a6c6d140&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2554971819","title":"Citius Oncology, Inc.7月25日成交额为499.93万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554971819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554971819?lang=zh_cn&edition=full","pubTime":"2025-07-26 09:49","pubTimestamp":1753494546,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Citius Oncology, Inc.成交额为499.93万美元，成交额较昨日增加131.20%，当日成交量为229.49万股。Citius Oncology, Inc.于2025年7月25日涨1.03%，报1.97美元，该股过去5个交易日涨28.76%，年初至今涨71.3%，过去60日涨120.36%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-25|499.93万|131.20%|229.49万|#|2025-07-24|216.23万|-95.36%|114.40万|#|2025-07-23|4664.69万|6627.26%|1957.31万|#|2025-07-22|69.34万|31.14%|43.63万|#|2025-07-21|52.88万|-42.43%|34.50万|Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726094910a6c273a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726094910a6c273a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2552484012","title":"Citius Oncology, Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552484012?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:44","pubTimestamp":1752759894,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时44分，Citius Oncology, Inc.股票出现波动，股价快速上涨5.10%。Citius Oncology, Inc.股票所在的制药行业中，整体跌幅为0.66%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Medicus Pharma Ltd C/Wts 15/11/2029、Scilex Holding Company涨幅较大，Incannex Healthcare Inc.、Gelteq Limited、Shuttle Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为31.47%、6.73%、4.23%，振幅较大的相关个股有Im Cannabis Corp.、Gelteq Limited、Durect Corporation，振幅分别为10.49%、9.68%、7.16%。Citius Oncology, Inc.公司简介：Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214454a451453c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214454a451453c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","GELS","BK4007","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.citiusonc.com","stockEarnings":[{"period":"1week","weight":0.009},{"period":"1month","weight":-0.1567},{"period":"3month","weight":-0.4084},{"period":"6month","weight":-0.2313},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0174}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Citius Oncology, Inc.（前身为TenX Keane Acquisition）于2021年3月1日在开曼群岛注册成立，并于2024年8月5日作为特拉华州公司迁移并归化。Citius Oncology将作为一个平台，开发和商业化新型靶向肿瘤疗法。2024年8月，其主要资产LYMPHIR获得FDA批准，用于治疗至少接受过一次全身治疗的复发或难治性CTCL成人患者。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.016846},{"month":2,"riseRate":0.666667,"avgChangeRate":0.001848},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.070112},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.017645},{"month":5,"riseRate":1,"avgChangeRate":0.020372},{"month":6,"riseRate":0.666667,"avgChangeRate":1.280036},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.177544},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.282178},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.091201},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.091127},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.146553},{"month":12,"riseRate":0.666667,"avgChangeRate":0.025958}],"exchange":"NASDAQ","name":"CITIUS ONCOLOGY INC","nameEN":"CITIUS ONCOLOGY INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CITIUS ONCOLOGY INC(CTOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CITIUS ONCOLOGY INC(CTOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CITIUS ONCOLOGY INC,CTOR,CITIUS ONCOLOGY INC股票,CITIUS ONCOLOGY INC股票老虎,CITIUS ONCOLOGY INC股票老虎国际,CITIUS ONCOLOGY INC行情,CITIUS ONCOLOGY INC股票行情,CITIUS ONCOLOGY INC股价,CITIUS ONCOLOGY INC股市,CITIUS ONCOLOGY INC股票价格,CITIUS ONCOLOGY INC股票交易,CITIUS ONCOLOGY INC股票购买,CITIUS ONCOLOGY INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CITIUS ONCOLOGY INC(CTOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CITIUS ONCOLOGY INC(CTOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}